English  |  正體中文  |  简体中文  |  Items with full text/Total items : 17939/22958 (78%)
Visitors : 7382806      Online Users : 124
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    Please use this identifier to cite or link to this item: https://ir.csmu.edu.tw:8080/ir/handle/310902500/18206


    Title: Elevated plasma matrix metalloproteinase-9 protein and its gene polymorphism in patients with community-acquired pneumonia
    Authors: Chiang, T.-Y.;Shyu, L.-Y.;Tsao, Tsao T.-C.Y.;Chien, M.-H.;Tsao, S.-M.;Lee, Y.-T.;Yang, S.-F.
    Keywords: community-acquired pneumonia;gene polymorphism;metalloproteinase-9 (MMP-9)
    Date: 2012
    Issue Date: 2017-08-09T03:25:52Z (UTC)
    ISSN: 14346621
    Abstract: Background: The purpose here was to detect the association among plasma matrix metalloproteinase-9 (MMP-9) concentration, single nucleotide polymorphisms (SNPs) of MMP-9 gene and community-acquired pneumonia (CAP). Methods: The enzyme-linked immunosorbent assay (ELISA) and polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) were, respectively used to measure the plasma MMP-9 level and its gene polymorphisms. Results: The level of plasma of MMP-9 was elevated in patients with CAP as compared to that of normal controls and decreased significantly after treatment. Plasma MMP-9 concentration was significantly correlated with white blood cell (WBC) and neutrophil counts in patients with CAP. No significant difference was found in the genotypes distribution of MMP-9 SNPs, rs3918242, rs17576 or rs2274756, between patients with CAP and normal controls. Plasma MMP-9 concentration was not associated with MMP-9 polymorphism. When the cut-off level of the plasma MMP-9 concentration was set to be 105.02 ng/mL, the odds ratio of plasma MMP-9 for CAP risk was 9.86 (95 confident interval: 4.2722.75). Plasma MMP-9 level may act as a prediction marker for CAP. Conclusions: Elevated plasma MMP-9 could be a biological marker for the diagnosis and be a new strategy for target therapy of community-acquired pneumonia. © 2012 by Walter de Gruyter Berlin Boston.
    URI: http://dx.doi.org/10.1515/cclm.2011.805
    https://www.scopus.com/inward/record.uri?eid=2-s2.0-84860435518&doi=10.1515%2fcclm.2011.805&partnerID=40&md5=b2d683d7b897c880817c7f56b3732f75
    https://ir.csmu.edu.tw:8080/ir/handle/310902500/18206
    Relation: Clinical Chemistry and Laboratory Medicine 50(3) ,449-454
    Appears in Collections:[醫學系] 期刊論文

    Files in This Item:

    There are no files associated with this item.



    SFX Query

    All items in CSMUIR are protected by copyright, with all rights reserved.


    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback